Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

INSPIRIS China PMCF Study

← catalyst calendar

NCT05404880 · readout ≤ 865 d

Sponsored by Edwards Lifesciences (industry) · EW — their whole pipeline →. With Edwards (Shanghai) Lifesciences Medical Supplies Co., Ltd., Rundo International Pharmaceutical Research & Development Co.,Ltd., Chinese Academy of Medical Sciences, Fuwai Hospital.

Phase
Status
Active, not recruiting
Study type
Observational
Enrollment
255actual
Sites
13
Country
China

Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →

Source: ClinicalTrials.gov, retrieved 2026-08-19

Dates

each axis at the precision it was filed, with the registry's own basis
DateFiledBasisWhat it is
Start2022-07-13actualWhen the study began enrolling
Primary completionDec 2028estimatedThe date the last participant is measured for the primary outcome — the readout window
Study completionDec 2029estimatedThe whole study's end, after follow-up
First posted2022-06-03actualWhen this record first appeared on the registry
Results postedWhen the sponsor posted results to the registry
Record updated2026-03-25actualThe sponsor's own last edit to this record — every projection above is as current as this date

What it studies

Condition

  • Aortic Valve Replacement

Intervention

  • Device: EDWARDS INSPIRIS RESILIA Aortic Valve

Primary outcomes

what the primary-completion date above is the date OF
Subject's Occurrence Rate of Study Valve Related Death
measured 5 Years
Subject's Occurrence Rate of Structural Valve Deterioration
measured 5 Years
Subject's Occurrence Rate of Re-operation on the Study Valve
measured 5 Years
Subject's Occurrence Rate of Major Bleeding
measured 5 Years
Subject's Occurrence Rate of Thromboembolic Events
measured 5 Years
Subject's Occurrence Rate of Stroke
measured 5 Years
Subject's Occurrence Rate of Transient Ischemic Attack
measured 5 Years
Subject's Occurrence Rate of Non-Cerebral Thromboembolism
measured 5 Years

Permalink · EW's whole pipeline · Catalyst calendar · Every registered study · What changed